Kedalion Therapeutics
Menlo Park
About Kedalion Therapeutics
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies for both new and existing indications. When compared to standard eye drops, Kedalion's proprietary AcuStream platform technology delivers topical drugs to the eye in a precise and accurate manner, enabling comparable effects with up to an 80% reduction in dose. AcuStream is a novel, digitally connected, electromechanical topical ocular delivery device that aims to fill a potential unmet need for a convenient, user-friendly device that reliably, accurately, and comfortably delivers topical ocular therapy with increased efficiency and patient comfort.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Series B (Nov 2021)
- Website: kedalionthera.com
- Phone: 6504614503
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kedalion-therapeutics-160719 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.